Innovative Oncology Focus ZielBio specializes in groundbreaking drug discovery for cancer treatment, positioning it as a key partner for biotech firms and healthcare providers seeking advanced oncology therapeutics.
Strategic Leadership Changes The recent appointment of a new CEO indicates strategic leadership that may open opportunities for partnerships aligned with innovative drug development and expansion into new markets.
Strong Investment Backing With a significant $25 million Series A funding from Morningside Ventures, ZielBio demonstrates strong investor confidence, suggesting readiness for growth and potential collaborations in cutting-edge biotech research.
Early-Stage Potential As a clinical-stage company with limited revenue, ZielBio offers opportunities for early partnership, licensing deals, and funding collaborations to support its pipeline development.
Technological Foundation Utilizing advanced cloud and web technologies, ZielBio is equipped with modern digital tools that can facilitate partnerships for data sharing, biotech research, and collaborative innovation.
ZielBio, Inc. uses 8 technology products and services including Open Graph, RSS, Google Cloud, and more. Explore ZielBio, Inc.'s tech stack below.
| ZielBio, Inc. Email Formats | Percentage |
| FLast@zielbio.com | 50% |
| FLast@zielbio.com | 50% |
Biotechnology ResearchVirginia , United States11-50 Employees
ZielBio is a clinical-stage biotechnology company using groundbreaking technology to identify druggable and specific targets that have the potential to radically change how we treat disease. We are currently advancing several therapeutics to expand treatment options and meaningfully improve the live of patients with cancer.
Company Overview
Media & News
Funding & FinancialsZielBio, Inc.'s revenue is estimated to be in the range of $1M
Funding & FinancialsZielBio, Inc.'s revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com